Elizabeth Holmes’s potential prison term for defrauding investors, like her company’s blood-testing technology, will likely fall short of what is advertised, according to an analysis of federal data b...
Elizabeth Holmes’s potential prison term for defrauding investors, like her company’s blood-testing technology, will likely fall short of what is advertised, according to an analysis of federal data b...